Biopsy Positioner

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. July 3, 2019 FUJIFILM Corporation % Mr. Jeffrey Wan Specialist, Regulatory Affairs FUJIFILM Medical Systems U.S.A., Inc. 81 Hartwell Avenue, Suite 300 LEXINGTON MA 02421 Re: K191495 Trade/Device Name: Biopsy Positioner (FDR -2000BPY) Regulation Number: 21 CFR 892.1710 Regulation Name: Mammographic x-ray system Regulatory Class: Class II Product Code: IZH Dated: May 31, 2019 Received: June 5, 2019 Dear Mr. Wan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's {1}------------------------------------------------ requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # Indications for Use 510(k) Number (if known) K191495 Device Name BIOPSY POSITIONER(FDR-2000BPY) #### Indications for Use (Describe) The FUJIFILM Biopsy Positioner (FDR-2000BPY) is an optional accessory for the Aspire Cristalle (FDR MS-3500) digital mammography system. It is designed to allow for accurate determination of three dimensional lesion locations in the breast using information extracted from stereotactic pairs of two-dimensional images and/or Digital Breast Tomosynthesis (DBT) images. It is intended to provide guidance for interventional purposes (such as biopsy, pre-surgical localization or treatment devices). | Type of Use (Select one or both, as applicable) | | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | <span> <div style="display:inline-block;"> <div style="display:inline-block;"> ☒ Prescription Use (Part 21 CFR 801 Subpart D) </div> </div> </span> | <span> <div style="display:inline-block;"> <div style="display:inline-block;"> ☐ Over-The-Counter Use (21 CFR 801 Subpart C) </div> </div> </span> | | CONTINUE ON A SEPARATE PAGE IF NEEDED. | | | This section applies only to requirements of the Paperwork Reduction Act of 1995. | | | <b>*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*</b> | | | The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: | | | Department of Health and Human Services<br>Food and Drug Administration<br>Office of Chief Information Officer<br>Paperwork Reduction Act (PRA) Staff<br>PRAStaff@fda.hhs.gov | | | "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | | ============================================================================================================================================================================== {3}------------------------------------------------ # 510(k) Summary K191495 Date Prepared: July 3, 2019 # Submitter's Information: FUJIFILM Corporation 798 Miyanodai Kaisei-Machi Ashigarakami-Gun, Kanagawa, 258-8538, Japan FDA Establishment Registration Number: 3001722928 #### Contact Person: Jeffrey Wan Specialist, Regulatory Affairs Telephone: (201) 675-8947 Email: jeffrey.wan@fujifilm.com ### Device Name and Classification: | Product Name: | Biopsy Positioner | |-----------------------|---------------------------| | Model Number: | FDR-2000BPY | | Classification Name: | Mammographic X-ray system | | Classification Panel: | Radiology | | CFR Section: | 21 CFR 892.1710 | | Device Class: | Class II | | Product Code: | IZH | #### Predicate Devices: | | Primary Predicate | Reference Predicate | |-------------------------|----------------------------------------------|-----------------------------------------| | Product Name | FUJIFILM Biopsy Positioner (FDR-<br>1000BPY) | Affirm Breast Biopsy Guidance<br>System | | 510(k) Number | K113284 | K122836 | | Classification<br>Name | Mammographic X-ray system | Mammographic X-ray system | | Classification<br>Panel | Radiology | Radiology | | CFR Section | 21 CFR 892.1710 | 21 CFR 892.1710 | | Device Class | Class II | Class II | | Product Code | IZH | IZH | {4}------------------------------------------------ #### Indications for Use: The FUJIFILM Biopsy Positioner (FDR-2000BPY) is an optional accessory for the Aspire Cristalle (FDR MS-3500) digital mammography system. It is designed to allow for accurate determination of three dimensional lesion locations in the breast using information extracted from stereotactic pairs of two-dimensional images and/or Digital Breast Tomosynthesis (DBT) images. It is intended to provide quidance for interventional purposes (such as biopsy, pre-surqical localization or treatment devices). ## Description of the Device: The Biopsy Positioner (FDR-2000BPY) is an optional accessory for the Digital Mammography system. It is designed for positioning the needle when performing Stereotactic and/or Tomosynthesis Biopsies, fine needle aspirations, core needle, and vacuum assisted biopsies in an upright position. The Biopsy Positioner uses a Stereo pair of images and/or Tomosynthesis images. The position of the three coordinates (X, Y, and Z) is computed using the position of the object on each of the images, as indicated by the operator, and the known geometry of the system. FDR-2000BPY is mainly composed of the following elements: - The Positioner that supports and positions the needle . - The Positioner Control Cabinet which supplies power to the positioned . - The Operation panel which displays the distance between the compression plate and . target pathology, the distance between the target pathology and the needle, and also electrically drives the positioner in the X, Y and Z directions. The subject of this Special 510(k) premarket notification is addinq use of Digital Breast Tomosynthesis (DBT) images for extracting information to determine three dimensional lesion locations in the breast. ## Comparison of Technological Characteristics: The Biopsy Positioner (FDR-2000BPY) differs from the predicate device in the following modifications: - Addition of tomosynthesis biopsy feature - Compatibility with additional needle guides ● A comparison of the technological characteristics between the proposed device and predicate devices is provided below: {5}------------------------------------------------ | | Biopsy Positioner (FDR-2000BPY) | Biopsy Positioner (FDR-1000BPY) | Affirm Breast Biopsy Guidance System | | |------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------| | K number | K191495 | K113284 | K122836 | | | IFU | The FUJIFILM Biopsy Positioner (FDR-2000BPY) is an optional accessory for the Aspire Cristalle (FDR MS-3500) digital mammography system. It is designed to allow for accurate determination of three dimensional lesion locations in the breast using information extracted from stereotactic pairs of two-dimensional images and/or Digital Breast Tomosynthesis (DBT) images. It is intended to provide guidance for interventional purposes (such as biopsy, pre-surgical localization or treatment devices). | The FUJIFILM Biopsy Positioner (FDR-1000BPY) is an optional accessory for the Aspire HD (FDR MS-1000) digital mammography system. It is designed to allow for accurate determination of three dimensional lesion locations in the breast using information extracted from stereotactic pairs of two-dimensional images. It is intended to provide guidance for interventional purposes (such as biopsy, pre-surgical localization or treatment devices). | The Affirm Breast Biopsy Guidance System is an optional accessory for the Selenia Dimensions Mammography System. It is designed to allow the accurate localization of lesions in the breast in three dimensions. It is intended to provide guidance for interventional purposes (such as biopsy, pre-surgical localization or treatment devices) | | | Biopsy<br>system | Type of biopsy | Same as K122836 | Stereo Biopsy | Stereo Biopsy<br>Tomosynthesis Biopsy | | | Exposure<br>position | Same as K122836 | $\pm$ 15°(Stereo Exposure) | $\pm$ 15°(Stereo Exposure)<br>$\pm$ 7.5°(Tomosynthesis Exposure) | | | Positioning<br>accuracy | Same as K113284 | $\pm$ 1mm | $\pm$ 1mm | | | Weight | Same as K113284 | Biopsy Unit 5.5kg | 7.0kg | | | Positioning<br>method | Same as K113284 | Electrically & Manually | Electrically & Manually | | | Method of beam<br>limitation | Same as K113284 | Automatic collimation | Automatic collimation | | | Size of biopsy<br>Field of View | Same as K113284 | 6.0cm x 7.0cm | 5.4cm x 5.2cm<br>7.4cm x 6.2cm | | | Lateral Approach | Same as K113284 | Yes | Yes | {6}------------------------------------------------ | | | Biopsy Positioner (FDR-2000BPY) | Biopsy Positioner (FDR-1000BPY) | |-----------------------|-----------------------------------------------------------------------|---------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------| | Compression<br>system | Construction<br>material / type<br>of biopsy<br>compression<br>paddle | Same as K113284 | Plastic | | | Lockout<br>movement<br>when under<br>compression | Same as K113284 | All movements shall be inhibited when:<br>• The compression force is detected to<br>be more than 30N<br>• The needle is attached to the needle<br>holder | | | Automatic<br>detection of<br>biopsy unit | Same as K113284 | Yes (alarm sounds and warning displayed or<br>indication panel if not connected properly) | | Needle<br>Guide | Needle guide<br>positioning | Same as K113284 | Yes | | | Positioning<br>software | Same as K113284 | Fujifilm | | | Calibration<br>frequency | Same as K113284 | User executes the accuracy testing at every<br>use and an annual maintenance check is<br>performed | | | Mammotome-<br>compatible<br>Devicor Medical<br>Products | Same as K113284 | Yes | | | Mammotome<br>Revolve | Yes | No | | | Hologic<br>ATEC/Eviva | Yes | No | | | BARD<br>Compatible | Same as K113284 | Yes | #### Performance Data: Biopsy Positioner (FDR-2000BPY) was evaluated for electromagnetic compatibility and radiation safety when used with the Aspire Cristalle (FDR MS-3500) digital mammography system in accordance with IEC 60601-1-2:2014, IEC 60601-1-3:2013, and IEC 60601-2-45:2015. The proposed device met all acceptance criteria described in these standards. Software validation was evaluated in accordance with ANSI/AAMI/IEC 62304:2006 and the FDA guidance, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices". Bench testing was performed on the Biopsy Positioner (FDR-2000BPY) to evaluate the stereotactic and tomosynthesis biopsy needle positioning accuracy when used with the Aspire Cristalle (FDR MS-3500) digital mammography system. {7}------------------------------------------------ #### Substantial Equivalence The modified FUJIFILM Biopsy Positioner (FDR-2000BPY) is adding the intended use with Digital Breast Tomosynthesis (DBT) images for extracting information to determine three dimensional lesion locations in the breast. Both the modified and primary predicate devices have the same fundamental scientific technology, principles of operation, performance, and design and materials. The addition of the tomosynthesis biopsy feature is supported by the reference predicate device. Therefore, FDR-2000BPY can be considered to be substantially equivalent to FDR-1000BPY. #### Conclusion: This Special 510(k) premarket notification submission has demonstrated Substantial Equivalence as defined and understood in the Federal Food Drug and Cosmetic Act and various guidance documents issued by the Center for Devices and Radiological Health. We conclude the subject device to be as safe and effective as the predicate device.